Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Laboratory Corporation of America Holdings (LH)
NYSE:LH
RESEARCH TOOLSreports
Holding LH?
Track your performance easily
LH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$191.97 - $247.99
Previous CloseN/A
Volume103.18K
Average Volume (3M)516.54K
Market Cap
$20.58B
Enterprise Value$25.08B
Total Cash (Recent Filing)$433.60M
Total Debt (Recent Filing)$5.30B
Price to Earnings (P/E)47.6
Beta0.54
Next Earnings
Feb 06, 2025EPS Estimate
3.39Next Dividend Ex-Date
Feb 27, 2025Dividend Yield1.17%
Share Statistics
EPS (TTM)5.16
Shares Outstanding83,639,260
10 Day Avg. Volume561,833
30 Day Avg. Volume516,537
Standard Deviation0.09
R-Squared0.41
Alpha-0.00261
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.62
Price to Cash Flow (P/CF)18.60
P/FCF Ratio25.90
Enterprise Value/Market Cap1.22
Enterprise Value/Revenue1.97
Enterprise Value/Gross Profit7.45
Enterprise Value/Ebitda16.21
Forecast
1Y Price Target
$270.75Price Target Upside8.95% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
Laboratory Corporation of America Holdings News
PremiumCompany Announcements
Labcorp to Participate in J.P. Morgan Healthcare Conference
PremiumCompany Announcements
Labcorp Declares Quarterly Cash Dividend for 2025
PremiumCompany Announcements
Labcorp to Announce Q4 2024 Financial Results
Bulls Say, Bears Say
Bulls Say
Financial PerformanceDiagnostics revenue grew approximately 9% year-over-year, with about 6% organic growth despite the impact of weather.
Market PositionNumerous headwinds are expected to flip, and labs are viewed as an attractive sector to invest in due to strong fundamentals that are largely defensive in nature.
Operational GrowthStrong organic volumes, stable to positive price, and benefits from hospital lab management agreements were reported, along with increased esoteric testing from new tests and increasing consumer demand.
Bears Say
EarningsUpdated 2024 adjusted EPS was reduced $0.10 at the midpoint, reflecting the negative impact from weather.
Financial PerformanceDiagnostics operating margin was down year-over-year due to various headwinds, and margins are expected to be down year-over-year in 2024.
Mergers And AcquisitionsThe Invitae deal surprised the market due to Invitae's historical negative margin profile, with near-term dilution being a concern.
---
Ownership Overview
0.32% Insiders
28.16% Mutual Funds
0.55% Other Institutional Investors
47.36% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
LH FAQ
What was Laboratory Corporation of America Holdings’s price range in the past 12 months?
Laboratory Corporation of America Holdings lowest stock price was $191.97 and its highest was $247.99 in the past 12 months.
What is Laboratory Corporation of America Holdings’s market cap?
Laboratory Corporation of America Holdings’s market cap is $20.58B.
When is Laboratory Corporation of America Holdings’s upcoming earnings report date?
Laboratory Corporation of America Holdings’s upcoming earnings report date is Feb 06, 2025 which is in 7 days.
How were Laboratory Corporation of America Holdings’s earnings last quarter?
Laboratory Corporation of America Holdings released its earnings results on Oct 24, 2024. The company reported $3.5 earnings per share for the quarter, beating the consensus estimate of $3.473 by $0.027.
Is Laboratory Corporation of America Holdings overvalued?
According to Wall Street analysts Laboratory Corporation of America Holdings’s price is currently Undervalued.
Does Laboratory Corporation of America Holdings pay dividends?
Laboratory Corporation of America Holdings pays a Quarterly dividend of $2.88 which represents an annual dividend yield of 1.17%. See more information on Laboratory Corporation of America Holdings dividends here
What is Laboratory Corporation of America Holdings’s EPS estimate?
Laboratory Corporation of America Holdings’s EPS estimate is 3.39.
How many shares outstanding does Laboratory Corporation of America Holdings have?
Laboratory Corporation of America Holdings has 83,639,260 shares outstanding.
What happened to Laboratory Corporation of America Holdings’s price movement after its last earnings report?
Laboratory Corporation of America Holdings reported an EPS of $3.5 in its last earnings report, beating expectations of $3.473. Following the earnings report the stock price went up 4.625%.
Which hedge fund is a major shareholder of Laboratory Corporation of America Holdings?
Currently, no hedge funds are holding shares in LH
---
Laboratory Corporation of America Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$270.75 (8.95% Upside)
$270.75 (8.95% Upside)
Blogger Sentiment
Neutral
LH Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 22.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $4.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 0.1%
Last 30 Days ▲ 3.6%
Last 30 Days ▲ 3.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
11.58%
12-Months-Change
Fundamentals
Return on Equity
5.43%
Trailing 12-Months
Asset Growth
10.22%
Trailing 12-Months
Company Description
Laboratory Corporation of America Holdings
Laboratory Corp. of America Holdings is a clinical laboratory company, which engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the LabCorp Diagnostics and Covance Drug Development segments. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment involves in providing drug development solutions, to companies in the pharmaceutical and biotechnology industries. The company was founded in 1971 and is headquartered in Burlington, NC.
---
LH Company Deck
---
LH Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected strong financial performance and positive outlooks in various segments, including diagnostics and oncology advancements. However, challenges in early development and margin pressures due to acquisitions and weather presented concerns.Read More>---
LH Revenue Breakdown
77.42% Dx
22.81% BLS
---
LH Stock 12 Month Forecast
Average Price Target
$270.75
▲(8.95% Upside)
Technical Analysis
Best Analysts Covering LH
1 Year
1 Year Success Rate
20/22 ratings generated profit
1 Year Average Return
+15.88%
reiterated a buy rating last month
Copying Erin Wright's trades and holding each position for 1 Year would result in 90.91% of your transactions generating a profit, with an average return of +15.88% per trade.
---